Champions Oncology, Inc. (CSBR)
5.075
-0.02
(-0.40%)
USD |
NASDAQ |
Sep 11, 16:00
5.075
0.00 (0.00%)
After-Hours: 16:43
Champions Oncology Gross Profit (TTM) : 28.93M for July 31, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| July 31, 2026 | 28.93M |
| April 30, 2026 | 27.19M |
| January 31, 2026 | 25.13M |
| October 31, 2025 | 27.77M |
| July 31, 2025 | 26.02M |
| April 30, 2025 | 27.36M |
| January 31, 2025 | 29.43M |
| October 31, 2024 | 23.57M |
| July 31, 2024 | 22.86M |
| April 30, 2024 | 20.75M |
| January 31, 2024 | 19.74M |
| October 31, 2023 | 20.64M |
| July 31, 2023 | 22.52M |
| April 30, 2023 | 24.34M |
| January 31, 2023 | 25.26M |
| October 31, 2022 | 26.97M |
| July 31, 2022 | 26.31M |
| April 30, 2022 | 25.48M |
| January 31, 2022 | 23.73M |
| October 31, 2021 | 23.14M |
| July 31, 2021 | 21.43M |
| April 30, 2021 | 19.78M |
| January 31, 2021 | 18.63M |
| October 31, 2020 | 17.13M |
| July 31, 2020 | 16.40M |
| Date | Value |
|---|---|
| April 30, 2020 | 15.18M |
| January 31, 2020 | 14.83M |
| October 31, 2019 | 13.15M |
| July 31, 2019 | 12.64M |
| April 30, 2019 | 12.80M |
| January 31, 2019 | 11.49M |
| October 31, 2018 | 11.10M |
| July 31, 2018 | 10.40M |
| April 30, 2018 | 9.653M |
| January 31, 2018 | 8.699M |
| October 31, 2017 | 7.249M |
| July 31, 2017 | 6.953M |
| April 30, 2017 | 5.709M |
| January 31, 2017 | 5.055M |
| October 31, 2016 | 4.342M |
| July 31, 2016 | 3.048M |
| April 30, 2016 | 2.45M |
| January 31, 2016 | 2.978M |
| October 31, 2015 | 2.386M |
| July 31, 2015 | 1.589M |
| April 30, 2015 | 1.23M |
| January 31, 2015 | 1.126M |
| October 31, 2014 | 3.34M |
| July 31, 2014 | 4.13M |
| April 30, 2014 | 5.289M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Medpace Holdings, Inc. | 772.42M |
| Avantor, Inc. | 2.012B |
| Personalis, Inc. | 8.838M |
| Adaptive Biotechnologies Corp. | 224.00M |
| 10X Genomics, Inc. | 435.44M |